/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

J

Junji Kishimoto

Kyushu University(JP)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

238

Papers

6.3K

Citations

43

h-index

107

i10-index

Junji Kishimoto is an academic researcher from Kyushu University. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Colorectal Cancer Treatments and Studies & Lung Cancer Diagnosis and Treatment. The author has an h-index of 43, co-authored 203 publications.

ORCID: 0000-0002-3833-4052

Research Topics

Lung Cancer Treatments and Mutations Colorectal Cancer Treatments and Studies Lung Cancer Diagnosis and Treatment Lung Cancer Research Studies Gastric Cancer Management and Outcomes

Papers by this author

works

Trastuzumab emtansine for patients with non–small cell lung cancer positive for human epidermal growth factor receptor 2 exon-20 insertion mutations

2021 · European Journal of Cancer · 74 citations

https://doi.org/10.1016/j.ejca.2021.11.021

Eiji Iwama Yoshitaka Zenke Shunichi Sugawara Haruko Daga

Blood biomarkers of Hikikomori, a severe social withdrawal syndrome

2018 · Scientific Reports · 66 citations

https://doi.org/10.1038/s41598-018-21260-w

Kohei Hayakawa Takahiro A. Kato Motoki Watabe Alan R. Teo

Tryptophan-kynurenine and lipid related metabolites as blood biomarkers for first-episode drug-naïve patients with major depressive disorder: An exploratory pilot case-control study

2018 · Journal of Affective Disorders · 63 citations

https://doi.org/10.1016/j.jad.2018.01.014

Nobuki Kuwano Takahiro A. Kato Daiki Setoyama Mina Sato‐Kasai

Safety, tolerability, and anti-fibrotic efficacy of the CBP/β-catenin inhibitor PRI-724 in patients with hepatitis C and B virus-induced liver cirrhosis: An investigator-initiated, open-label, non-randomised, multicentre, phase 1/2a study

2022 · EBioMedicine · 53 citations

https://doi.org/10.1016/j.ebiom.2022.104069

Kiminori Kimura Tatsuya Kanto Shinji Shimoda Kenichi Harada

Treatment Rationale and Design for J-SONIC: A Randomized Study of Carboplatin Plus Nab-paclitaxel With or Without Nintedanib for Advanced Non–Small-cell Lung Cancer With Idiopathic Pulmonary Fibrosis

2017 · Clinical Lung Cancer · 46 citations

https://doi.org/10.1016/j.cllc.2017.06.003

Kohei Otsubo Junji Kishimoto Hirotsugu Kenmotsu Yuji Minegishi

T-bet+ lymphocytes infiltration as an independent better prognostic indicator for triple-negative breast cancer

2019 · Breast Cancer Research and Treatment · 30 citations

https://doi.org/10.1007/s10549-019-05256-2

Hitomi Mori Makoto Kubo Masaya Kai Mai Yamada

Research topics

topics

Lung Cancer Treatments and Mutations

Colorectal Cancer Treatments and Studies

Lung Cancer Diagnosis and Treatment

Lung Cancer Research Studies

Gastric Cancer Management and Outcomes

Chat about Author

Papers

Chat

Click to start Chat